GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,263,000 | +339.5% | 19,653 | +111.8% | 0.11% | +197.3% |
| Q4 2019 | $970,000 | +6366.7% | 9,277 | +7036.2% | 0.04% | +3600.0% |
| Q3 2019 | $15,000 | -40.0% | 130 | -9.7% | 0.00% | 0.0% |
| Q2 2019 | $25,000 | -91.2% | 144 | -91.4% | 0.00% | -93.8% |
| Q1 2019 | $283,000 | -9.9% | 1,679 | -47.9% | 0.02% | -23.8% |
| Q4 2018 | $314,000 | -28.5% | 3,220 | +26.8% | 0.02% | -16.0% |
| Q3 2018 | $439,000 | -25.3% | 2,540 | -39.7% | 0.02% | -32.4% |
| Q2 2018 | $588,000 | +1.6% | 4,213 | -18.1% | 0.04% | -11.9% |
| Q1 2018 | $579,000 | +46.6% | 5,143 | +71.9% | 0.04% | +31.2% |
| Q4 2017 | $395,000 | +19.7% | 2,992 | +20.5% | 0.03% | -8.6% |
| Q3 2016 | $330,000 | +72.8% | 2,483 | -77.4% | 0.04% | +12.9% |
| Q3 2013 | $191,000 | – | 11,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |